PCR203 A Review of the Quality-of-Life Data Use in French Economic and Public Health Assessment Committee’s (CEESP) Efficiency Opinions for Immune-Checkpoint Inhibitors (ICIS) and Chimeric Antigen Receptor T (CAR-T CELL THERAPIES)
Abstract
Authors
A Gueye H Lemasson AF Gaudin M Baklouti